Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $1,216,353 | |
| Profit allocation | Retained in reserve capital | |
| Loans and borrowings | 1 items | |
| Capital expenditure | $534,530 | |
| Planned capital expenditure (next year) | $510,296 | |
| Foreign sales | 1.27% of revenue ($449,897) |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 96 days for 2021). All were audited by a statutory auditor.
- 202505/08/2026
- 202430/07/2025
- 202311/06/2024
- 202203/07/2023
- 202119/10/2022
- 202005/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Trademarks
Exeltis Poland holds 6 active trademarks registered with the Polish Patent Office. 22 marks have expired or were not registered. The first mark was filed in 2006.
| Mark | Protected until | |
|---|---|---|
| AXYVEN(word) | Dec 4, 2028 | |
| ABIOFEM(word) | Dec 4, 2028 | |
| Atywia | Jun 25, 2027 | |
| Atycja | Jun 25, 2027 | |
| Zalanzo | Jun 25, 2027 |
Authorized Representatives
Manner of representation
Authorized to make declarations of will on behalf of the company and to represent it are: 1) in the case of a one-person management board, one member of the management board independently; 2) in the case of a management board consisting of two or more members, two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Alkmaar Export B.v. | 77,680 | $1,049,162.61 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2005-12-09.
90 1030 1508 0000 0008 0371 9012- 40 1030 1508 0000 0008 0371 9039
- 96 1030 1508 0000 0008 0371 9098
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 145.8KPLN 145,837 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $30,214$30,214 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $44,233$44,233 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $27,774$27,774 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biomerieux Polskasp. z o.o. | $48,134,147.81 | biomerieux.com | ||
| Procardia Medicalsp. z o.o. | $43,909,591.35 | procardia.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Ascensia Diabetes Care Polandsp. z o.o. | $45,797,496.38 | diabetes.ascensia.pl | ||
| TMSsp. z o.o. | $37,494,900.41 | tms.com.pl | ||
| Sysmex Polskasp. z o.o. | $37,091,282.03 | sysmex.pl | ||
| Urgosp. z o.o. | $30,883,357.15 | urgopolska.pl | ||
| Medev Medical Devices Polskasp. z o.o. | $28,150,076.74 | medev.pl | ||
| Glenmark Pharmaceuticalssp. z o.o. | $26,934,644.29 | glenmarkpharma.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-06-29 | Address change (Ul. Gen. Józefa Zajączka 9, 01-518, Warszawa → Ul. Szamocka 8, 01-748, Warszawa) | |
| 2015-11-10 | Address change (Żwirki I Wigury 81, 02-091, Warszawa → Ul. Gen. Józefa Zajączka 9, 01-518, Warszawa) | |
| 2015-11-10 | Name change (Temapharm → Exeltis Poland) | |
| 2015-07-14 | PKD change (Removed: 64.19.Z, 64.99.Z, 66.19.Z, 68.20.Z, 68.32.Z, 70.22.Z) | |
| 2014-10-24 | PKD change (Added: 64.19.Z, 64.92.Z, 64.99.Z, 66.19.Z) |
FAQ
Last updated: 2026-10-07